Antibody-Drug Conjugates (ADCs) are a fundamental technology in modern tumor-targeted therapy with their ‘tripartite integrated design’ of ‘precision carrier - stable linker - potent payload’: The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback